{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:31:23Z","timestamp":1769106683142,"version":"3.49.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T00:00:00Z","timestamp":1430092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0125164","type":"journal-article","created":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T18:11:29Z","timestamp":1430158289000},"page":"e0125164","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"isrctn43070564","registry":"10.18810\/isrctn"}],"author":[{"given":"Laurent","family":"Fauchier","sequence":"first","affiliation":[]},{"given":"Nicola","family":"Greenlaw","sequence":"additional","affiliation":[]},{"given":"Roberto","family":"Ferrari","sequence":"additional","affiliation":[]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[]},{"given":"Kim M.","family":"Fox","sequence":"additional","affiliation":[]},{"given":"Jean-Claude","family":"Tardif","sequence":"additional","affiliation":[]},{"given":"Michal","family":"Tendera","sequence":"additional","affiliation":[]},{"given":"Ph. Gabriel","family":"Steg","sequence":"additional","affiliation":[]},{"name":"CLARIFY Investigators","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2015,4,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"AJ Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization","volume":"31","author":"W Wijns","year":"2010","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(09)61751-7","article-title":"Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data","volume":"374","author":"R Sorensen","year":"2009","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1093\/eurheartj\/ehs289","article-title":"Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry","volume":"33","author":"PG Steg","year":"2012","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"GY Lip","year":"2010","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"R Pisters","year":"2010","journal-title":"Chest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ahj.2008.06.029","article-title":"Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis","volume":"156","author":"S Goto","year":"2008","journal-title":"Am Heart J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2007.11.035","article-title":"Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis","volume":"51","author":"JM Ruiz-Nodar","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1378\/chest.10-2719","article-title":"Coronary stent implantation in patients committed to long-term oral anticoagulation therapy: successfully navigating the treatment options","volume":"139","author":"A Rubboli","year":"2011","journal-title":"Chest"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1253\/circj.CJ-09-0880","article-title":"Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation","volume":"74","author":"F Gao","year":"2010","journal-title":"Circ J"},{"key":"ref11","first-page":"260","article-title":""Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment","volume":"139","author":"HJ Zhao","year":"2011","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"WJ Dewilde","year":"2013","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.thromres.2012.05.016","article-title":"Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation","volume":"130","author":"E Aguilar","year":"2012","journal-title":"Thromb Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/CIRCULATIONAHA.113.004564","article-title":"Antithrombotic therapy for patients with atrial fibrillation and atherothrombotic vascular disease: striking the right balance between efficacy and safety","volume":"128","author":"C Patrono","year":"2013","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ahj.2007.03.008","article-title":"Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation","volume":"153","author":"R Nieuwlaat","year":"2007","journal-title":"Am Heart J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2005.06.077","article-title":"Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation","volume":"46","author":"AL Waldo","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1378\/chest.10-2436","article-title":"Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project","volume":"140","author":"L Gorin","year":"2011","journal-title":"Chest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/hrt.75.2.200","article-title":"Physician variation in the management of patients with atrial fibrillation","volume":"75","author":"GY Lip","year":"1996","journal-title":"Heart"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/archinte.163.13.1580","article-title":"Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded","volume":"163","author":"M Man-Son-Hing","year":"2003","journal-title":"Arch Intern Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1445-5994.2002.00156.x","article-title":"Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention","volume":"32","author":"GM Peterson","year":"2002","journal-title":"Intern Med J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/eurheartj\/ehq250","article-title":"Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W","volume":"31","author":"R De Caterina","year":"2010","journal-title":"Eur Heart J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1160\/TH09-08-0580","article-title":"Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary intervention\/ stenting","volume":"103","author":"GY Lip","year":"2010","journal-title":"Thromb Haemost"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"S Connolly","year":"2006","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1160\/TH11-04-0262","article-title":"Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective","volume":"106","author":"DP Faxon","year":"2011","journal-title":"Thromb Haemost"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1160\/TH11-08-0602","article-title":"Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: similarities and dissimilarities between North America and Europe","volume":"106","author":"K Huber","year":"2011","journal-title":"Thromb Haemost"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","article-title":"Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy","volume":"364","author":"EP McFadden","year":"2004","journal-title":"Lancet"},{"key":"ref27","article-title":"2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","author":"CT January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jacc.2012.02.008","article-title":"New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper","volume":"59","author":"R De Caterina","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCULATIONAHA.111.055970","article-title":"Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial","volume":"125","author":"SH Hohnloser","year":"2012","journal-title":"Circulation"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0125164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:59:17Z","timestamp":1588985957000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0125164"}},"subtitle":[],"editor":[{"given":"Marc W.","family":"Merx","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2015,4,27]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0125164","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,27]]}}}